The impact of comorbid disease history on all-cause and cancer-specific mortality in myeloid leukemia and myeloma – a Swedish population-based study
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The impact of comorbid disease history on all-cause and cancer-specific mortality in myeloid leukemia and myeloma – a Swedish population-based study
Authors
Keywords
Acute Myeloid Leukemia, Myeloma, Chronic Myeloid Leukemia, Hematological Malignancy, Acute Myeloid Leukemia Patient
Journal
BMC CANCER
Volume 15, Issue 1, Pages -
Publisher
Springer Nature
Online
2015-11-05
DOI
10.1186/s12885-015-1857-x
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Treatment of elderly patients with acute myeloid leukemia adjusted for performance status and presence of comorbidities: a Polish Adult Leukemia Group study
- (2015) Bozena Katarzyna Budziszewska et al. LEUKEMIA & LYMPHOMA
- Correlation between Charlson comorbidity index and outcome in patients with chronic phase chronic myeloid leukemia treated with second-generation tyrosine kinase inhibitors upfront
- (2015) Massimo Breccia et al. LEUKEMIA & LYMPHOMA
- Acute Leukemia
- (2014) Hayley Rose-Inman et al. EMERGENCY MEDICINE CLINICS OF NORTH AMERICA
- Cancer-specific administrative data–based comorbidity indices provided valid alternative to Charlson and National Cancer Institute Indices
- (2014) Diana Sarfati et al. JOURNAL OF CLINICAL EPIDEMIOLOGY
- Comorbidity and performance status in acute myeloid leukemia patients: a nation-wide population-based cohort study
- (2014) L S G Østgård et al. LEUKEMIA
- Age influences initial dose and compliance to imatinib in chronic myeloid leukemia elderly patients but concomitant comorbidities appear to influence overall and event-free survival
- (2014) Massimo Breccia et al. LEUKEMIA RESEARCH
- European Perspective on Multiple Myeloma Treatment Strategies in 2014
- (2014) H. Ludwig et al. ONCOLOGIST
- Tyrosine kinase inhibitor usage, treatment outcome, and prognostic scores in CML: report from the population-based Swedish CML registry
- (2013) M. Hoglund et al. BLOOD
- Flexible parametric modelling of cause-specific hazards to estimate cumulative incidence functions
- (2013) Sally R Hinchliffe et al. BMC Medical Research Methodology
- How can we make cancer survival statistics more useful for patients and clinicians: An illustration using localized prostate cancer in Sweden
- (2013) Sandra Eloranta et al. CANCER CAUSES & CONTROL
- Validation of the Freiburg Comorbidity Index in 466 Multiple Myeloma Patients and Combination With the International Staging System Are Highly Predictive for Outcome
- (2013) Martina Kleber et al. Clinical Lymphoma Myeloma & Leukemia
- Imatinib in Very Elderly Patients with Chronic Myeloid Leukemia in Chronic Phase: A Retrospective Study
- (2013) Roberto Latagliata et al. DRUGS & AGING
- Comorbidities and polypharmacy impact on complete cytogenetic response in chronic myeloid leukaemia elderly patients
- (2013) Alessandra Iurlo et al. European Journal of Internal Medicine
- Validation of the Hematopoietic Cell Transplantation-Specific Comorbidity Index: a prospective, multicenter GITMO study
- (2012) R. Raimondi et al. BLOOD
- Comorbidity in elderly cancer patients in relation to overall and cancer-specific mortality
- (2012) T L Jørgensen et al. BRITISH JOURNAL OF CANCER
- Survival for older patients with acute myeloid leukemia: a population-based study
- (2012) B. Oran et al. HAEMATOLOGICA
- Imatinib treatment duration is related to decreased estimated glomerular filtration rate in chronic myeloid leukemia patients
- (2011) M. S. Marcolino et al. ANNALS OF ONCOLOGY
- External review and validation of the Swedish national inpatient register
- (2011) Jonas F Ludvigsson et al. BMC PUBLIC HEALTH
- Role of HCT-comorbidity index, age and disease status at transplantation in predicting survival and non-relapse mortality in patients with myelodysplasia and leukemia undergoing reduced-intensity-conditioning hemopoeitic progenitor cell transplantation
- (2011) S W Bokhari et al. BONE MARROW TRANSPLANTATION
- Cancer statistics, 2011
- (2011) Rebecca Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Rheumatologic manifestations of benign and malignant haematological disorders
- (2011) Vinod Ravindran et al. CLINICAL RHEUMATOLOGY
- Comorbidity and survival after early breast cancer. A review
- (2011) Lotte Holm Land et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- Charlson comorbidity index and adult comorbidity evaluation-27 scores might predict treatment compliance and development of pleural effusions in elderly patients with chronic myeloid leukemia treated with second-line dasatinib
- (2011) M. Breccia et al. HAEMATOLOGICA
- Charlson Comorbidity Index is an independent prognostic factor among elderly patients with diffuse large B-cell lymphoma
- (2011) Yujin Kobayashi et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Success Story of Targeted Therapy in Chronic Myeloid Leukemia: A Population-Based Study of Patients Diagnosed in Sweden From 1973 to 2008
- (2011) Magnus Björkholm et al. JOURNAL OF CLINICAL ONCOLOGY
- Comorbidity, Treatment and Mortality: A Population Based Cohort Study of Prostate Cancer in PCBaSe Sweden
- (2011) Anders Berglund et al. JOURNAL OF UROLOGY
- Comorbidity as a risk factor for overall survival and decision criteria for intensity of chemotherapy in elderly patients with acute myeloid leukemia
- (2011) Irena Djunic et al. MEDICAL ONCOLOGY
- Comorbidity as a prognostic variable in multiple myeloma: comparative evaluation of common comorbidity scores and use of a novel MM–comorbidity score
- (2011) M Kleber et al. Blood Cancer Journal
- Prognostic value of comorbidity for auto-SCT eligibility and outcome in relapsed or refractory aggressive non-Hodgkin's lymphoma
- (2010) W J Plattel et al. BONE MARROW TRANSPLANTATION
- Renal function in newly diagnosed multiple myeloma - A demographic study of 1353 patients
- (2010) Lene Meldgaard Knudsen et al. EUROPEAN JOURNAL OF HAEMATOLOGY
- Improved Estimates of Cancer-Specific Survival Rates From Population-Based Data
- (2010) Nadia Howlader et al. JNCI-Journal of the National Cancer Institute
- Comorbidities and FLT3-ITD abnormalities as independent prognostic indicators of survival in Elderly acute myeloid leukaemia patients
- (2009) Massimo Breccia et al. HEMATOLOGICAL ONCOLOGY
- Unexplained differences between hospital and mortality data indicated mistakes in death certification: an investigation of 1,094 deaths in Sweden during 1995
- (2009) Lars Age Johansson et al. JOURNAL OF CLINICAL EPIDEMIOLOGY
- Socioeconomic Differences in Patient Survival Are Increasing for Acute Myeloid Leukemia and Multiple Myeloma in Sweden
- (2009) Sigurdur Yngvi Kristinsson et al. JOURNAL OF CLINICAL ONCOLOGY
- The hematopoietic cell transplantation comorbidity index (HCT-CI) predicts clinical outcomes in lymphoma and myeloma patients after reduced-intensity or non-myeloablative allogeneic stem cell transplantation
- (2009) L Farina et al. LEUKEMIA
- How to treat elderly patients with multiple myeloma: combination of therapy or sequencing
- (2009) A. Palumbo et al. Hematology-American Society of Hematology Education Program
- The completeness of the Swedish Cancer Register – a sample survey for year 1998
- (2008) Lotti Barlow et al. ACTA ONCOLOGICA
- Age and acute myeloid leukemia: real world data on decision to treat and outcomes from the Swedish Acute Leukemia Registry
- (2008) G. Juliusson et al. BLOOD
- Impact of comorbidity indexes on non-relapse mortality
- (2008) A Xhaard et al. LEUKEMIA
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started